SYNEOS HEALTH, INC. SYNH Income Statement

Syneos health, inc. (SYNH)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Revenue
4,720,164	4,675,815	4,608,333	4,546,223	4,451,926	4,390,116	4,321,327	4,028,737	3,347,342	2,672,064	2,001,452	1,570,915	1,579,427	1,610,596	1,607,410	1,565,764	1,503,409	1,399,239	1,324,009	1,272,488	1,220,939	1,178,799	0	0	0
Costs and operating expenses:
Direct costs (exclusive of depreciation and amortization)
0	-	0	0	0	-	0	0	0	-	-	-	629,410	-	614,612	590,501	569,014	542,404	532,945	526,972	519,743	515,059	0	0	0
Selling, general, and administrative expenses
451,134	446,281	443,745	430,824	420,163	406,305	402,720	394,632	336,945	282,620	220,888	173,776	173,841	172,386	171,073	169,759	164,288	156,609	154,165	151,921	148,758	145,143	0	0	0
Restructuring and other costs
36,442	42,135	48,897	54,790	51,499	50,793	62,336	49,657	45,095	33,315	15,955	12,166	9,501	13,612	10,502	7,593	8,241	1,785	1,632	4,611	5,016	6,192	0	0	0
Transaction and integration-related expenses
52,194	61,275	37,803	45,910	56,288	64,841	77,538	143,317	149,024	123,815	108,367	25,154	2,584	3,143	3,572	2,848	2,076	1,637	6,782	6,379	5,982	7,902	0	0	0
Asset impairment charges
-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	3,931	3,931	3,931	21,176	17,245	0	0	0
Depreciation
74,186	76,532	76,597	75,392	73,701	72,158	71,352	67,762	56,271	44,407	32,375	23,631	22,625	21,353	19,854	18,906	18,266	18,140	18,534	18,911	19,516	21,619	0	0	0
Amortization
163,186	165,933	175,617	184,719	193,163	201,527	215,553	216,541	176,058	135,529	79,772	37,853	37,854	37,851	37,849	37,847	37,857	37,874	38,000	38,135	34,900	32,924	0	0	0
Total operating expenses
4,460,259	4,438,061	4,374,472	4,341,988	4,275,103	4,229,934	4,225,593	4,061,708	3,400,785	2,700,930	2,001,538	1,442,717	1,421,824	1,455,237	1,456,158	1,409,567	1,350,928	1,246,879	1,192,889	1,162,970	1,139,488	1,115,155	0	0	0
Income from operations
259,905	237,754	233,861	204,235	176,823	160,182	95,734	-32,971	-53,443	-28,866	-86	128,198	157,603	155,359	151,252	156,197	152,481	152,360	131,120	109,518	81,451	63,644	0	0	0
Other (income) expense, net:
Interest income
6,376	7,542	6,249	4,827	4,349	3,686	3,915	3,412	1,909	1,182	842	403	294	216	174	140	142	192	180	178	151	249	0	0	0
Interest expense
121,648	129,820	134,474	134,964	133,595	130,701	127,634	121,969	92,361	63,725	36,517	12,311	12,112	12,016	12,270	12,109	13,255	15,640	23,870	33,734	42,342	53,036	0	0	0
Loss on extinguishment of debt
14,750	10,395	-4,594	-6,383	-8,260	-4,153	-4,434	-2,747	-870	-622	-541	0	0	-	0	-	-	-	0	0	-	-	0	0	-
Other (income) expense, net
-52,013	-24,162	60,350	25,291	49,719	28,244	11,419	9,812	-28,943	-19,846	-14,405	-10,836	-7,342	-9,002	-11,042	-9,661	-4,726	3,857	5,650	11,789	9,777	7,689	0	0	0
Total other expense, net
-175,257	-136,045	2,497	-36,263	-12,821	-102,924	-116,734	-111,492	-120,265	-83,011	-50,182	-23,183	-19,599	-21,241	-23,577	-21,630	-27,634	-21,386	-74,585	-78,312	-79,164	-91,848	0	0	0
Income (loss) before provision for income taxes
163,109	101,709	143,558	75,158	71,158	57,258	-20,972	-144,446	-173,684	-111,877	-50,268	105,015	138,004	134,118	127,675	134,567	124,847	130,974	56,535	31,206	2,287	-28,204	0	0	0
Income tax expense
-31,749	-29,549	57,774	58,674	52,374	32,974	15,375	29,499	10,472	26,592	35,663	15,617	21,592	21,488	21,880	18,289	15,651	13,927	19,924	19,854	-1,051	-4,734	0	0	0
Net income (loss)
194,836	131,258	85,878	16,564	18,832	24,284	-36,433	-174,037	-184,208	-138,469	-85,931	89,398	116,412	112,630	105,795	116,278	109,196	117,047	36,611	11,352	3,338	-23,470	0	0	0
Class C common stock dividends
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	375	0	0	0
Net income (loss) attributable to common shareholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-27,220	0	0	0
Earnings (loss) per share:
Basic (USD per share)
0.32	0.88	0.57	0.11	-0.29	0.44	-0.10	0.13	-0.24	-0.60	-1.70	0.06	0.39	0.70	0.50	0.56	0.32	0.54	0.67	0.40	0.41	-1.01	0.24	0.29	-0.03
Diluted (USD per share)
0.32	0.87	0.56	0.11	-0.29	0.44	-0.10	0.13	-0.24	-0.59	-1.70	0.06	0.38	0.69	0.49	0.54	0.31	0.52	0.64	0.39	0.40	-1.01	0.24	0.29	-0.03
Weighted average common shares outstanding:
Basic (in shares)
104,265	103,814	103,594	103,699	103,365	103,296	103,012	102,899	104,449	104,362	87,152	54,123	54,015	53,685	54,186	54,298	53,955	55,752	56,325	58,231	61,244	57,504	51,905	51,898	51,897
Diluted (in shares)
105,642	106,816	105,021	104,818	103,365	107,338	103,012	104,005	104,449	102,070	87,152	55,307	55,123	54,933	55,567	56,078	55,862	58,253	58,764	60,464	63,103	56,608	52,514	52,185	51,897
Revenue
Revenue
-	-	-	-	-	-	-	-	-	-	-	-	1,033,418	1,030,337	1,008,714	983,651	952,223	914,740	887,109	860,378	836,542	809,728	0	0	0
Reimbursable out-of-pocket expenses
Revenue
-	-	-	-	-	-	-	-	-	-	-	-	546,009	580,259	598,696	582,113	551,186	484,499	436,900	412,110	384,397	369,071	0	0	0